Clifford C Shaw
Examiner (ID: 13369)
Most Active Art Unit | 2106 |
Art Unit(s) | 0, 2103, 2106, 1725, 3201, 1742, 1793, 3203, 1104 |
Total Applications | 2810 |
Issued Applications | 2569 |
Pending Applications | 74 |
Abandoned Applications | 166 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 2930750
[patent_doc_number] => 05232933
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-08-03
[patent_title] => 'Method for treatment of neurodegenerative diseases'
[patent_app_type] => 1
[patent_app_number] => 7/887196
[patent_app_country] => US
[patent_app_date] => 1992-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2952
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/232/05232933.pdf
[firstpage_image] =>[orig_patent_app_number] => 887196
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/887196 | Method for treatment of neurodegenerative diseases | May 20, 1992 | Issued |
Array
(
[id] => 2953608
[patent_doc_number] => 05242915
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-09-07
[patent_title] => 'Formulation useful for the inhibition of massive release of cerebral glutamate'
[patent_app_type] => 1
[patent_app_number] => 7/885864
[patent_app_country] => US
[patent_app_date] => 1992-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4456
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/242/05242915.pdf
[firstpage_image] =>[orig_patent_app_number] => 885864
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/885864 | Formulation useful for the inhibition of massive release of cerebral glutamate | May 19, 1992 | Issued |
Array
(
[id] => 2921981
[patent_doc_number] => 05200410
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-04-06
[patent_title] => 'Medicaments for the treatment of cerebral apoplexy'
[patent_app_type] => 1
[patent_app_number] => 7/884488
[patent_app_country] => US
[patent_app_date] => 1992-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3780
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/200/05200410.pdf
[firstpage_image] =>[orig_patent_app_number] => 884488
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/884488 | Medicaments for the treatment of cerebral apoplexy | May 14, 1992 | Issued |
Array
(
[id] => 2986871
[patent_doc_number] => 05266594
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-11-30
[patent_title] => 'Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity'
[patent_app_type] => 1
[patent_app_number] => 7/881900
[patent_app_country] => US
[patent_app_date] => 1992-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 14
[patent_no_of_words] => 5777
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/266/05266594.pdf
[firstpage_image] =>[orig_patent_app_number] => 881900
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/881900 | Inhibitors of nitric oxide synthase and use thereof to prevent glutamate neurotoxicity | May 11, 1992 | Issued |
Array
(
[id] => 2895489
[patent_doc_number] => 05183819
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-02-02
[patent_title] => 'Use of fused bicyclic imides in the treatment of various CNS disorders'
[patent_app_type] => 1
[patent_app_number] => 7/881443
[patent_app_country] => US
[patent_app_date] => 1992-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2863
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/183/05183819.pdf
[firstpage_image] =>[orig_patent_app_number] => 881443
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/881443 | Use of fused bicyclic imides in the treatment of various CNS disorders | May 10, 1992 | Issued |
Array
(
[id] => 2918188
[patent_doc_number] => 05206267
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-04-27
[patent_title] => 'Pain controlling composition and method of preparation'
[patent_app_type] => 1
[patent_app_number] => 7/870767
[patent_app_country] => US
[patent_app_date] => 1992-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3075
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/206/05206267.pdf
[firstpage_image] =>[orig_patent_app_number] => 870767
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/870767 | Pain controlling composition and method of preparation | Apr 19, 1992 | Issued |
Array
(
[id] => 3051019
[patent_doc_number] => 05283263
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-02-01
[patent_title] => 'Method for treating certain psychiatric disorders and certain psychiatric symptoms'
[patent_app_type] => 1
[patent_app_number] => 7/870360
[patent_app_country] => US
[patent_app_date] => 1992-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9040
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/283/05283263.pdf
[firstpage_image] =>[orig_patent_app_number] => 870360
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/870360 | Method for treating certain psychiatric disorders and certain psychiatric symptoms | Apr 16, 1992 | Issued |
Array
(
[id] => 2917623
[patent_doc_number] => 05206238
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-04-27
[patent_title] => 'Cholecystokinin antagonists'
[patent_app_type] => 1
[patent_app_number] => 7/870157
[patent_app_country] => US
[patent_app_date] => 1992-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9262
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 643
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/206/05206238.pdf
[firstpage_image] =>[orig_patent_app_number] => 870157
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/870157 | Cholecystokinin antagonists | Apr 14, 1992 | Issued |
07/866597 | METHOD FOR TREATMENT OF NEURODEGENERATIVE DISEASES | Apr 9, 1992 | Abandoned |
Array
(
[id] => 2910754
[patent_doc_number] => 05227391
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-07-13
[patent_title] => 'Method for treatment of neurodegenerative diseases'
[patent_app_type] => 1
[patent_app_number] => 7/866596
[patent_app_country] => US
[patent_app_date] => 1992-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3006
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/227/05227391.pdf
[firstpage_image] =>[orig_patent_app_number] => 866596
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/866596 | Method for treatment of neurodegenerative diseases | Apr 9, 1992 | Issued |
Array
(
[id] => 2934592
[patent_doc_number] => 05229405
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-07-20
[patent_title] => 'Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients'
[patent_app_type] => 1
[patent_app_number] => 7/866926
[patent_app_country] => US
[patent_app_date] => 1992-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6227
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/229/05229405.pdf
[firstpage_image] =>[orig_patent_app_number] => 866926
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/866926 | Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients | Apr 9, 1992 | Issued |
Array
(
[id] => 2886152
[patent_doc_number] => 05214060
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-05-25
[patent_title] => 'Method for treatment of neurodegenerative diseases'
[patent_app_type] => 1
[patent_app_number] => 7/866594
[patent_app_country] => US
[patent_app_date] => 1992-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3016
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/214/05214060.pdf
[firstpage_image] =>[orig_patent_app_number] => 866594
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/866594 | Method for treatment of neurodegenerative diseases | Apr 9, 1992 | Issued |
Array
(
[id] => 2927921
[patent_doc_number] => 05187169
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-02-16
[patent_title] => 'Method for treatment of neurodegenerative diseases'
[patent_app_type] => 1
[patent_app_number] => 7/866698
[patent_app_country] => US
[patent_app_date] => 1992-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2955
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/187/05187169.pdf
[firstpage_image] =>[orig_patent_app_number] => 866698
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/866698 | Method for treatment of neurodegenerative diseases | Apr 9, 1992 | Issued |
Array
(
[id] => 2906780
[patent_doc_number] => 05216019
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-06-01
[patent_title] => 'Pain killer'
[patent_app_type] => 1
[patent_app_number] => 7/865822
[patent_app_country] => US
[patent_app_date] => 1992-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2586
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/216/05216019.pdf
[firstpage_image] =>[orig_patent_app_number] => 865822
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/865822 | Pain killer | Mar 31, 1992 | Issued |
Array
(
[id] => 3094856
[patent_doc_number] => 05292766
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-08
[patent_title] => 'Method for improving primary memory and/or learning'
[patent_app_type] => 1
[patent_app_number] => 7/857521
[patent_app_country] => US
[patent_app_date] => 1992-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10922
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/292/05292766.pdf
[firstpage_image] =>[orig_patent_app_number] => 857521
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/857521 | Method for improving primary memory and/or learning | Mar 24, 1992 | Issued |
Array
(
[id] => 2900639
[patent_doc_number] => 05217999
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-06-08
[patent_title] => 'Styryl compounds which inhibit EGF receptor protein tyrosine kinase'
[patent_app_type] => 1
[patent_app_number] => 7/856849
[patent_app_country] => US
[patent_app_date] => 1992-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 10044
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 312
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/217/05217999.pdf
[firstpage_image] =>[orig_patent_app_number] => 856849
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/856849 | Styryl compounds which inhibit EGF receptor protein tyrosine kinase | Mar 23, 1992 | Issued |
Array
(
[id] => 2885804
[patent_doc_number] => 05214042
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-05-25
[patent_title] => 'Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents'
[patent_app_type] => 1
[patent_app_number] => 7/855361
[patent_app_country] => US
[patent_app_date] => 1992-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6627
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/214/05214042.pdf
[firstpage_image] =>[orig_patent_app_number] => 855361
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/855361 | Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents | Mar 17, 1992 | Issued |
Array
(
[id] => 2910643
[patent_doc_number] => 05227385
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-07-13
[patent_title] => 'Method for treatment of neurodegenerative diseases'
[patent_app_type] => 1
[patent_app_number] => 7/850624
[patent_app_country] => US
[patent_app_date] => 1992-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3829
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/227/05227385.pdf
[firstpage_image] =>[orig_patent_app_number] => 850624
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/850624 | Method for treatment of neurodegenerative diseases | Mar 12, 1992 | Issued |
Array
(
[id] => 3087351
[patent_doc_number] => 05278160
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-01-11
[patent_title] => 'Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders'
[patent_app_type] => 1
[patent_app_number] => 7/848782
[patent_app_country] => US
[patent_app_date] => 1992-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10212
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/278/05278160.pdf
[firstpage_image] =>[orig_patent_app_number] => 848782
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/848782 | Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders | Mar 9, 1992 | Issued |
Array
(
[id] => 2910505
[patent_doc_number] => 05227378
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-07-13
[patent_title] => 'Combination of PAF antagonists and LTD.sub.4 antagonists for the treatment of allergic reactions'
[patent_app_type] => 1
[patent_app_number] => 7/848564
[patent_app_country] => US
[patent_app_date] => 1992-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5005
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/227/05227378.pdf
[firstpage_image] =>[orig_patent_app_number] => 848564
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/848564 | Combination of PAF antagonists and LTD.sub.4 antagonists for the treatment of allergic reactions | Mar 8, 1992 | Issued |